Abstract:The beta-amyloid hypothesis of Alzheimer's disease (AD) has resulted in current research focusing on lowering levels of brain beta-amyloid, a small peptide derived from amyloid precursor protein. Meanwhile, the signaling pathways downstream of beta-amyloid as well as beta-amyloid-independent mechanisms are also being vigorously pursued as potential disease-modifying targets. One such potential target is the protein kinase GCN2, which is important in controlling mRNA translation via phosphorylation of eukaryotic initiation factor 2α subunit (eIF2α). Interestingly, elevated eIF2α phosphorylation has been correlated with AD pathogenesis, potentially via mechanisms of oxidative stress. Here taking advantage of a mutant mouse model in which eIF2 a kinase GCN2 is deleted (GCN2 KO), we examined whether repression of eIF2α phosphorylation could alleviate synaptic and memory deficits associated with APP/PS1 AD model mice. Hippocampal long-term potentiation (LTP) was induced by high frequency-stimulation (HFS) at CA3-CA1 synapses. Spatial memory was estimated by doing Morris water maze. Immunofluorescence combined with confocal microscopy was used to detect dendritic co-localization. Western blot was used to examine regulation of protein levels. We found that phosphorylation of eIF2α was increased in human AD brains and in the hippocampus of APP/PS1 mutant mice, which are a model for AD. We also found that the increase in eIF2 a phosphorylation in the APP/PS1 mice was correlated with increases in the levels of GCN2 and ATF4 (activating transcription factor 4). Additionally, we found that GCN2 co-localized with phospho-eIF2α in dendritic processes of hippocampal neurons. In correlation, hippocampal LTP was intact in GCN2 KO mice treated with beta-amyloid 1–42 (500 nM), which caused LTP failure in wild type mice. Furthermore, we crossed APP/PS1 mouse with GCN2 KO mice and generated APP/PS1/GCN2 KO double mutant mice. We demonstrated that inhibition of eIF2α activity by deleting GCN2 prevented decline of spatial memory and synaptic function in APP/PS1 mouse (10–12 month old). Our findings indicate that AD-associated impairments in synaptic plasticity and memory can be prevented by decreasing GCN2-dependent eIF2 a phosphorylation, which might be linked to enhanced translation. These studies suggest that GCN2 and eIF2a are viable therapeutic targets for synaptic dysfunction in AD and other related dementia syndrome.

Impaired Hippocampal Long-Term Potentiation and Memory Deficits upon Haploinsufficiency of MDGA1 Can Be Rescued by Acute Administration of D-Cycloserine

Pumping the Brakes: Suppression of Synapse Development by MDGA–neuroligin Interactions

A Negative Regulator of Synaptic Development: MDGA and Its Links to Neurodevelopmental Disorders

MDGA2 Constrains Glutamatergic Inputs Selectively onto CA1 Pyramidal Neurons to Optimize Neural Circuits for Plasticity, Memory, and Social Behavior

Fragile X Mental Retardation Protein is Required for Chemically‐induced Long‐term Potentiation of the Hippocampus in Adult Mice

Decreased Synapse‐associated Proteins Are Associated with the Onset of Epileptic Memory Impairment in Endothelial CDK5‐deficient Mice

Improvement of Learning and Memory by Elevating Brain D-Aspartate in a Mouse Model of Fragile X Syndrome.

GSK-3β Deletion in Dentate Gyrus Excitatory Neuron Impairs Synaptic Plasticity and Memory

Deficiency of Glycosylated-Α-dystroglycan in Ventral Hippocampus Bridges the De-Stabilization of Gamma-Aminobutyric Acid Type A Receptors with the Depressive-Like Behaviors of Male Mice

Enhancing GluN2A-type NMDA receptors impairs long-term synaptic plasticity and learning and memory

Deficiency of Glycosylated α-Dystroglycan in Ventral Hippocampus Bridges the Destabilization of Gamma-Aminobutyric Acid Type A Receptors With the Depressive-like Behaviors of Male Mice

Loss of CDKL5 in Glutamatergic Neurons Disrupts Hippocampal Microcircuitry and Leads to Memory Impairment in Mice

Maged1 Co-interacting with CREB Through a Hexapeptide Repeat Domain Regulates Learning and Memory in Mice

Region- and age-dependent reductions of hippocampal long-term potentiation and NMDA to AMPA ratio in a genetic model of Alzheimer's disease

Deletion of the Mitochondrial Matrix Protein CyclophilinD Prevents Parvalbumin Interneuron Dysfunctionand Cognitive Deficits in a Mouse Model of NMDA Hypofunction

Behavioral Deficits and Subregion-Specific Suppression of LTP in Mice Expressing a Population of Mutant NMDA Receptors Throughout the Hippocampus

Suppression of Hippocampal GABAergic Transmission Impairs Memory in Rodent Models of Alzheimer's Disease.

GHSR1a deficiency suppresses inhibitory drive on dCA1 pyramidal neurons and contributes to memory reinforcement

O3–02–01: Reversal of Synaptic Plasticity and Spatial Memory Deficits in APP/PS1 Mice by Suppressing Protein Kinase GCN2

The N-Methyl-D-Aspartate Receptor Co-agonist D-Cycloserine Facilitates Declarative Learning and Hippocampal Activity in Humans

Hippocampal long-term potentiation suppressed by increased inhibition in the Ts65Dn mouse, a genetic model of Down syndrome